These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 991899)

  • 1. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between the direct capillary tube leucocyte migration technique (LMCT) and the direct agarose leucocyte migration technique (LMAT) as indicators of tumour-directed cell-mediated hypersensitivity (TCMH) in patients with renal carcinoma.
    Kjaer M; Sorensen IB
    Acta Allergol; 1976 Apr; 31(2):141-58. PubMed ID: 947138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
    Kjoer M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
    [No Abstract]   [Full Text] [Related]  

  • 5. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
    Kjaer M; Bendixen G
    Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
    Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
    Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leucocyte washings on cellular immunity to human renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Oct; 12(10):783-92. PubMed ID: 1086209
    [No Abstract]   [Full Text] [Related]  

  • 8. The dose-related effect of tumour extract on the in vitro migration of leucocytes from patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1975 Apr; 11(4):281-9. PubMed ID: 1095377
    [No Abstract]   [Full Text] [Related]  

  • 9. General immunocompetence and tumour-directed, cell-mediated hypersensitivity in vitro in patients with renal carcinoma.
    Kjaer M; Thomsen M
    Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):403-13. PubMed ID: 136864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-induced, cell-mediated hypersensitivity in man. A critical review with special reference to leucocyte migration assays.
    Kjaer M
    Acta Allergol; 1976 Oct; 31(5):373-415. PubMed ID: 790887
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma.
    Thatcher N; Barnard RJ; Gasiunas N; Crowther D
    Eur J Cancer (1965); 1977 Sep; 13(9):951-6. PubMed ID: 913478
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity in patients with renal adenocarcinoma.
    Bichler KH; Ax W; Tautz C
    Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.
    Montie JE; Straffon RA; Deodhar SD; Barna B
    J Urol; 1976 Mar; 115(3):239-42. PubMed ID: 1255882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
    Pappas A; Schwarze G
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
    [No Abstract]   [Full Text] [Related]  

  • 16. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspects of the study of immunity in patients with kidney tumors].
    Trapeznikova MF; Kadagidze ZG; Abramian NS; Dutov VV
    Urol Nefrol (Mosk); 1984; (4):18-21. PubMed ID: 6474622
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular immunity to renal carcinomas in man.
    Bubeník J; Jakoubková J; Krákora P; Baresová M; Helbich P; Viklický V; Malasková V
    Int J Cancer; 1971 Nov; 8(3):503-13. PubMed ID: 5137312
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
    Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
    Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cellular immunity in patients with renal carcinoma: radiation-induced inhibition of leukocyte migration.
    Schwarze G; Dietz R; Pappas A
    Eur J Cancer (1965); 1979 Feb; 15(2):205-10. PubMed ID: 436897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.